Other

Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent

West Pharmaceutical Services Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent increased by 200.0% to $100.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 75.0%, from $400.00K to $100.00K.

Analysis

StatementIncome Statement
SectionOther
First reportedQ2 2019
Last reportedQ1 2026Apr 23, 2026
Metric ID: other_other_comprehensive_income_defined_benefit_plans_a_3736b2

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value-$100.00K-$400.00K-$900.00K-$1.90M-$13.60M$500.00K$900.00K-$200.00K$200.00K$200.00K$800.00K$400.00K$700.00K-$100.00K$100.00K
QoQ Change—-300.0%-125.0%-111.1%-615.8%+103.7%+80.0%-122.2%+200.0%+0.0%+300.0%-50.0%+75.0%-114.3%+200.0%
YoY Change———<-999%<-999%+155.6%+147.4%+98.5%-60.0%-77.8%+500.0%+100.0%+250.0%-112.5%-75.0%
Range-$13.60M – $900.00K
CAGR+0.0%
Avg YoY Growth-347.8%
Median YoY Growth+19.3%

Frequently Asked Questions

What is West Pharmaceutical Services's other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent?
West Pharmaceutical Services (WST) reported other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent of $100.00K in Q1 2026.
How has West Pharmaceutical Services's other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent changed year-over-year?
West Pharmaceutical Services's other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent decreased by 75.0% year-over-year, from $400.00K to $100.00K.